18F-FAPI-04 PET/CT Imaging of Rare Brain Metastasis from Myxoid Pleomorphic Liposarcoma

Yong Wang1, Kelin Wang1, Dongfang Meng1

  • 1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong 250117 China.

Insights

This study details the first solitary brain metastasis from myxoid pleomorphic liposarcoma (MPLS) using 18F-FAPI-04 PET/CT. The imaging identified a "Halo Sign," aiding diagnosis of rare brain tumors.

Area of Science:

  • Oncology
  • Radiology
  • Molecular Imaging

Background:

  • Myxoid pleomorphic liposarcoma (MPLS) is a rare soft tissue sarcoma.
  • Brain metastases from MPLS are exceptionally uncommon.
  • Accurate characterization of rare metastases is crucial for treatment planning.

Purpose of the Study:

  • To report the first case of solitary brain metastasis from MPLS.
  • To evaluate the utility of 18F-FAPI-04 PET/CT in imaging this rare metastasis.
  • To investigate the imaging characteristics, including the "Halo Sign," associated with MPLS brain metastasis.

Main Methods:

  • A single patient with a solitary brain lesion was investigated.
  • The lesion was evaluated using 18F-FAPI-04 Positron Emission Tomography/Computed Tomography (PET/CT).
  • Imaging findings were analyzed for specific characteristics related to tumor infiltration.

Main Results:

  • The study identified a solitary brain metastasis from MPLS.
  • 18F-FAPI-04 PET/CT revealed a distinct "Halo Sign" in the metastasis.
  • The "Halo Sign" was attributed to the infiltration of cancer-associated fibroblasts (CAFs).

Conclusions:

  • 18F-FAPI-04 PET/CT is a valuable tool for characterizing rare brain metastases like MPLS.
  • The observed "Halo Sign" provides insights into tumor heterogeneity and fibroblast infiltration.
  • This imaging approach may improve the diagnosis and inform therapeutic strategies for rare brain metastases.